Alzheon
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Alzheon is a clinical-stage biopharmaceutical company founded in 2013 and based in Framingham, Massachusetts, USA. The company is dedicated to developing breakthrough, disease-modifying medicines for Alzheimer's disease and other neurodegenerative disorders. Its lead program is an oral, anti-amyloid oligomer therapy designed using a precision medicine approach.
Small Molecules